# Omran Saifi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/omran-saifi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 450 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 12 |
| i10-index | 18 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5013192671 |
| ORCID iD | 0000-0001-9400-4771 |
| Works | 60 |

## Researcher papers

- [Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?](https://scholariq.org/papers/does-bridging-radiation-therapy-affect-the-pattern-of-failure-after-car-t-cell/)
- [Next-Generation Boron Drugs and Rational Translational Studies Driving the Revival of BNCT](https://scholariq.org/papers/next-generation-boron-drugs-and-rational-translational-studies-driving-the/)
- [High-Cost Cancer Treatment Across Borders in Conflict Zones: Experience of Iraqi Patients in Lebanon](https://scholariq.org/papers/high-cost-cancer-treatment-across-borders-in-conflict-zones-experience-of-iraqi/)
- [Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma](https://scholariq.org/papers/don-t-put-the-cart-before-the-horse-the-role-of-radiation-therapy-in-peri-car-t/)
- [Is breast conservation superior to mastectomy in early stage triple negative breast cancer?](https://scholariq.org/papers/is-breast-conservation-superior-to-mastectomy-in-early-stage-triple-negative/)
- [<p>Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia</p>](https://scholariq.org/papers/and-lt-p-and-gt-implementation-of-pharmacogenetics-to-individualize-treatment/)
- [Incorporating radiation with anti‐CD19 chimeric antigen receptor T‐cell therapy for relapsed/refractory non‐Hodgkin lymphoma: A multicenter consensus approach](https://scholariq.org/papers/incorporating-radiation-with-anti-cd19-chimeric-antigen-receptor-t-cell-therapy/)
- [Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis](https://scholariq.org/papers/treatment-and-prognosis-of-hepatic-epithelioid-hemangioendothelioma-a-seer/)
- [Comprehensive Bridging Radiotherapy for Limited Pre-CART Non-Hodgkin Lymphoma](https://scholariq.org/papers/comprehensive-bridging-radiotherapy-for-limited-pre-cart-non-hodgkin-lymphoma/)
- [Comparable Efficacy of Reduced Dose Radiation Therapy for the Treatment of Early Stage Gastric Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue](https://scholariq.org/papers/comparable-efficacy-of-reduced-dose-radiation-therapy-for-the-treatment-of-early/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.